Abstract
Background:
Wide resection of infected bone increases the chances of eradication of infection in patients with chronic osteomyelitis. Aggressive debridement is, however, frequently complicated by the creation of large bone defects. The use of antibiotic-impregnated PMMA spacers, as a customized dead space management tool, has recently grown in popularity. In addition to certain biological advantages, the spacer also offers a therapeutic benefit by serving as a vehicle for delivery of local adjuvant antibiotics.
Methods:
This retrospective case series involved 11 patients with chronic osteomyelitis, managed with tibial bone transport through an induced membrane using circular external fixation. All patients were treated according to a standardized treatment protocol and we review the anatomic nature of the disease, the physiological status of the host, the surgical procedures performed, as well as the outcome of treatment in terms of eradication of infection, time to union and the complications that occurred.
Results:
Nine patients, with a mean bone defect of 6 cm (range: 2–8 cm) were included in the study. At a mean follow-up of 24 months (range: 14–45 months) eradication of osteomyelitis was achieved in all patients without the need for reoperation for infection. Failure of the skeletal reconstruction occurred in two patients. Six major and four minor complications were experienced. After a mean time of 70 weeks (range: 30 to 104 weeks) in the circular external fixator all but one docking site had united and all regenerated segments were consolidated.
Conclusion:
Bone transport, using circular external fixation, through the induced membrane created by the temporary insertion of a PMMA appears to be a useful technique in the management of post-infective tibial bone defects larger than 4 cm in size. Patient selection appears to be a crucial step in ensuring a successful outcome in terms of the resolution of infection.
